-
New
- Announcement | 2025 Outstanding International IP Service Teams
-
On 24 January, the 2026 Enterprise IP Strategy Forum and Annual Conference of In-house IP Managers kicked off at the Beijing International Hotel. At the grand party in that evening, winners of the 2025 Outstanding International IP Service Teams were unveiled.
-
New
- Consolidate & Elevate: Innovate to Cultivate the New—2026 Enterprise IP Strategy Forum & Annual Conference of In-House IP Managers Successfully Held
-
The Forum brought together industry leaders, experts, and premium institutions to provide enterprises with threefold value: trend analysis, resource matching, and capability enhancement. It represented a crucial collaborative opportunity for enterprises to seize industrial upgrading opportunities. A total of 420 distinguished guests from all industry sectors gathered at the venue, witnessing every highlight of this year's Forum together.
-
New
- Patents in Biotech & Pharma: Practical law & strategy for Italy and Europe
-
Patents remain the primary instrument to protect and monetise biotech and pharmaceutical innovations in Europe. In these sectors, the value of a single patent application can far exceed that seen in many other industries.
-
New
- China's innovation in Brazil: strong patent protection and enforcement
-
Chinese companies are increasingly active in Brazil’s consumer, automotive, ICT, and life sciences sectors, while also have securing and enforcing patents at high rates.
-
New
- Applications of Generative AI in Drugs Development and Materials Discovery: IP Considerations
-
This article reviews some genAI applications in these fields and dives into associated intellectual property (IP) issues.
-
New
- Guarding Openness with Private Rights: The Significance, Key Points and Strategies of Open-source Trademark Protection
-
Although trademark rights are private rights, they are not in conflict with the free and open spirit of open-source. They serve different purposes and work together to protect the open-source ecosystem and safeguard the legal rights of stakeholders.
-
New
- Why Filing German Patents is a Strategic Advantage for Chinese Applicants
-
This article explores why the DPMA should play a role in the European patent strategies of Chinese applicants and how it can serve as a gateway to success in the European market.
-
New
- AI and Patents——Innovative Turn or Risk to Innovation?
-
In recent years, Artificial Intelligence (AI) has evolved very rapidly in terms of performance and has revolutionized numerous fields, from medicine to finance, from industrial production to artistic creativity.
-
New
- Patent Litigation Strategies for Chinese Enterprises in Germany
-
Germany is by far one of China’s most important trading partner in Europe. Conversely, China is Germany’s number one economic partner country in Asia. Due to this interdependence, IP disputes involving Chinese companies are commonplace in Germany. This article will provide examples of patent litigation strategies for Chinese companies and focus on some key aspects of first instance proceedings, as well as provide salient suggestions.
-
New
- A Statistical Model for Analyzing the Lifetime Cost of Chinese Patents
-
The author has conducted a study investigating how a company's internal reviews and CNIPA examinations affect the lifetime cost of Chinese patents. A statistical model based on the Lognormal distribution of patent value and supported by empirical data was proposed to analyze the influences. The study considers all costs incurred throughout the innovation stage to the end of patent life. The findings suggest that the lifetime cost of a good patent can be minimized by a particular combination of the internal pass rate and the official grant rate.